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Identifying genes involved in neurodevelopmental defects is a 
major ongoing endeavor. Previously, catalogs of human brain 
enhancers and of polymorphisms within them have been pro-
duced and used to identify potential connections to schizophre-
nia and autism.1–4 On the other hand, genes functionally 
connected to these enhancers have just begun to be defined.5 In 
our article,6 we started to identify functional connections between 
genes and enhancers in the mouse genome, with a view to provide 
a basis for analysis of neural disease-relevant genes in humans.
Sox2 Function in the Transcriptional Regulation of 
Neural Cell Identity and Disease
We focused on the roles of the transcription factor Sox2 in regu-
lating the genome-wide interactions between genes and enhanc-
ers, thus shaping the global three-dimensional (3D) interactome.6 
Sox2 is necessary for the maintenance of both embryonic stem 
cells (ESCs)7 and neural stem cells (NSCs), both in vivo and in 
vitro.8 In man, Sox2 mutation results in hippocampal defects, eye 
defects, intellectual disability, and other neural defects.
The Role of Noncoding Elements in Regulating 
Development and Disease
Extensive effort has identified thousands of active enhancers in 
human and mouse neural cells using DNase sensitivity or chro-
matin immunoprecipitation of genomic sequences, bound by 
p300 or modified histones like H3K27ac, coupled with sequenc-
ing (ChIP-seq). These foundational atlases of neural enhancer 
identities have been a major contribution to the field of neural 
development and disease, but these studies did not reveal the 
specific gene promoter(s) that are directly regulated by each 
enhancer. Indeed, interactions between enhancers and promot-
ers cannot be understood using the aforementioned approaches, 
as these methods can only delineate the linear location of active 
enhancers along the length of a chromosome. However, the 
mammalian genome is organized in three dimensions through a 
complex looping arrangement that is relevant to transcriptional 
regulation.1,9 Inside the nucleus, chromosomes are extensively 
folded into chromatin loops that occupy distinct 3D territories. 
This highly organized 3D chromatin organization provides a 
topological basis for many genome functions, including tran-
scription, by bringing distal regulatory elements and their cog-
nate genes into close spatial proximity.9 Chromatin organization 
and enhancer-promoter interactions are highly dynamic during 
lineage specification.10,11 Long-range interactions connect 
genes (or gene promoters) to other promoters (promoter-pro-
moter interactions), or to distant regions (promoter-enhancer 
interactions) carrying enhancer marks, often skipping other 
intervening genes.
The Use of Chromatin Interaction Assays in Wild-
Type and Sox2-Deleted Brain-Derived NSC to 
Determine Sox2-Associated Interactions
At the genome level, these interactions (interactome) have 
been extensively characterized by techniques such as HiC and 
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Chromatin Interaction Analysis by Paired-End-Tag sequenc-
ing (ChIA-PET), which rely on the detection, by high-
throughput sequencing, of proximity ligated DNA fragments 
within fragmented fixed chromatin.2,9,11,12 These studies pro-
vided extensive catalogs of potential enhancers (and polymor-
phism within them), connected in various tissues to specific 
genes. At the genome-wide level, the regulatory functions of 
the detected enhancers and interactions have been so far 
addressed by few previous studies.2,5,12
We adopted RNApolII ChIA-PET (as well as an improved 
version of it, “in situ ChIA-PET”) to capture genome-wide 
chromatin interactions between genes and enhancers that are 
associated with RNA polymerase II (RNAPII) and, concomi-
tantly, to identify previously unrecognized enhancer elements 
in the mouse genome. We thus analyzed mouse brain-derived 
wild-type and Sox2-mutant neonatal NSC grown in vitro 
(Figure 1A). In parallel, we identified the genome-wide locali-
zation of DNA-bound Sox2, together with regions carrying 
histone modifications indicative of enhancer activity 
(H3K27Ac; H3K4me1). Overall, Sox2-bound interactions are 
about 36% to 46% of the total interactions, pointing to a poten-
tial role of Sox2 in the generation or maintenance of the NSC 
interactome. DNA-bound Sox2 is highly enriched within 
“enhancer regions” genome-wide; in particular, the proportion 
of total Sox2-bound “enhancers” that are represented within 
DNA fragments (anchors) involved in promoter-enhancer 
interactions is much higher than that of non-Sox2-bound 
“enhancer regions” (Figure 1B), pointing to a potential role of 
Sox2 specifically at the level of these interactions.
Sox2 Deletion Profoundly Affects the Pattern of 
Interactions in Neonatal NSC
In neonatal cultures obtained from the brain of mice in which 
Sox2 had been deleted during embryogenesis, the interactions 
are, in general, greatly reduced: some are largely lost, whereas 
others are less importantly affected in frequency (Figure 1A). 
The strong decrease in the frequency of some of the interac-
tions is indicative of a complete loss in a significant proportion 
of the cells.
The parallel study of the transcriptome indicates that Sox2-
deleted cells show significantly decreased expression of some 
700 genes. We looked for a correlation between the type of 
interaction identified for each downregulated gene, and its 
belonging to the category of genes that are downregulated in 
mutant NSC, versus nondownregulated genes. The “downreg-
ulated genes in mutant” category is quite significantly enriched 
in promoter-enhancer interactions, and even more in pro-
moter-Sox2+ enhancer interactions (in wild-type cells), 
whereas the “nondownregulated” category shows anticorrela-
tion with these characteristics (Figure 1C). These results indi-
cate that the activities of a significant fraction of genes are 
dependent on their interaction with an enhancer, in particular 
an Sox2-bound enhancer. Note that Sox2 deletion causes sig-
nificant alterations of the expression of several transcription 
factors, which might in turn contribute to the changes in the 
interactome; so, the observed correlation of gene downregula-
tion (in mutant cells) with gene interactions with Sox2-bound 
enhancers (in wild type cells) emerges on top of a background 
of effects not directly dependent on Sox2.
A similar analysis shows that promoter-promoter interac-
tions do not importantly affect the expression of genes in NSC, 
although their loss may correlate with minor decreases of 
expression in a subset of genes. Overall, our results stress the 
importance of promoter-enhancer interactions for transcrip-
tional regulation and indicate that the predominant functional 
effect of Sox2 on gene transcription is exerted by its binding to 
distal enhancers connected to regulated genes, rather than to 
promoters.
It is presently unclear whether Sox2 acts directly to bring 
about an interaction. It is possible that Sox2 acts by recruiting 
other transcription factors, generating complexes which form 
bridges connecting different DNA regions; additionally, Sox2 
might interact with structural factors able to create/maintain 
loops. YY1, a noncell type-specific factor, promotes the forma-
tion of a tissue-specific interactome in neural cells by binding 
to specific sequences13: it is tempting to speculate that YY1 
may collaborate with Sox2 in these processes. It will be inter-
esting to identify the binding of additional transcription factors 
in the proximity of Sox2 bound to anchors.
A large proportion of the genes involved in interactions 
with enhancers maintain their activity even after Sox2 loss; 
moreover, alterations in chromatin epigenetic marks are not 
detected in Sox2-deleted cells. There are several possible expla-
nations: (1) many genes have multiple interactions, and the 
more interactions a gene has, the greater its activity (on aver-
age). As not all of the interactions centered on a given gene are 
necessarily lost in Sox2-deleted cells, it is possible that the 
remaining interactions are sufficient to confer significantly 
high activity; (2) the maintenance of an “active gene” epigenetic 
configuration might contribute to preserve gene activity. This 
hypothesis implies that Sox2 might be required for the estab-
lishment of the active chromatin configuration, and of gene 
activity, that might then be maintained, upon later deletion of 
Sox2, by additional mechanisms (eg, binding of other tran-
scription factors recruited by the initial Sox2 binding); (3) 
interactions detected by ChIA-PET might represent a “snap-
shot” of a process (chromatin connectivity) that may be 
dynamic; (some) interactions might be successively in an “off ” 
or “on” state, in which case, loss of Sox2 might simply have 
altered (ie, decreased) the probability of persisting in, or enter-
ing into, the “on” state (resulting in the observed overall decrease 
of interactions).
Identification of Critical Genes for Sox2-Dependent 
NSC Maintenance
Why do Sox2-deleted NSC lose the ability to self-renew? We 
looked for genes that are likely directly regulated by Sox2 (ie, 
bound by Sox2 at the enhancer or promoter in NSC, or 
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stimulated by Sox2 in transgenic zebrafish assays), and that lose 
a large part of their expression in Sox2-deleted cells. Among 
several genes sharing these characteristics, we identified Socs3 
(suppressor of cytokine signaling), whose deletion is known to 
favor diversion of NSC into the glial differentiation pathway.6 
We then transduced Socs3, together with a green fluorescent 
Figure 1. Sox2-dependent interactions: (A) promoter-enhancer and promoter-promoter interactions are depicted in wild-type (top) and Sox2-deleted 
(bottom) NSC. Red indicates interactions decreased in mutant cells. (B) Sox2 binding overlaps with H3K27Ac+ nucleosomes (“enhancers”). The 
proportion of Sox2+ enhancers in interactions is much higher than the proportion of Sox2– enhancers (see text). (C) The loss of Sox2 from enhancers 
involved in promoter-enhancer interactions is the major factor responsible for downregulation of the connected gene. (D) Is loss of long-range interactions 
in Sox2-deleted NSC rescued by re-addition of Sox2, together with long-term self-renewal?
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protein (GFP) reporter gene, into Sox2-deleted NSC; this 
resulted in a progressive increase of the proportion of GFP+ 
cells, up to almost 100%, and the efficient long-term 
maintenance of the growth of these cells, well beyond the time 
when untransduced Sox2-deleted cells had all been lost from 
the culture. It is likely that additional genes will be identified by 
Figure 2. Long-range Sox2-bound interactions and human-inherited neurodevelopmental disease: (A) functional enhancers connected to mouse 
homologs of human neural disease genes may provide a clue to the identification of mutation/polymorphism in conserved human enhancers, responsible 
for disease. (B) Mouse homologs of genes involved in neurodevelopmental disease in man are significantly enriched in Sox2-bound promoter-enhancer 
interactions. Different types of microcephaly and intellectual disability are indicated. The proportion of Sox2-bound (red) to total genes considered (blue) 
is indicated (see Bertolini et al,6 Table S6). (C) Screenshots of interactions involving the PTEN-induced kinase 1 (PINK1) and Presenilin-2 (Psen2) genes, 
involved in Parkinson’s and Alzheimer’s disease, respectively.
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similar screens; these might either cooperate with Socs3, or 
might represent genes upstream to Socs3, and active, together 
with Sox2, on Socs3 regulation, thus defining a network of 
Sox2-dependent functional interactions.
The fact that Socs3 transduction rescues the maintenance of 
Sox2-deleted NSC raises the interesting question whether the 
altered long-range interactions pattern, and the correct gene 
expression levels, can be restored to normal in rescued Sox2-
deleted NSC. Initial work indicates that Sox2 transduction is 
also able to rescue NSC self-renewal; thus, the loss of self-
renewal is reversible in Sox2-deleted cells. ChIA-PET experi-
ments will address the issue of restoration of the correct 
interactome in these cells (Figure 1D).
Human Neural Disease-Relevant Gene Regulatory 
Networks and Identification of Functional Neural 
Enhancers
Our data offer an exciting potential strategy to identify patho-
genic noncoding variants affecting the function of their con-
nected genes involved in neural diseases in man. Many of the 
brain enhancers identified in our studies show one or more of 
these characteristics: (1) they stimulate forebrain expression of 
a reporter gene in zebrafish; (2) they coincide with enhancers 
active in early forebrain development in mouse14; and (3) they 
are highly significantly connected to genes whose human 
homologs are responsible, when mutated, for intellectual disa-
bility, microcephaly, vision disorders, Alzheimer and Parkinson 
diseases, and so on (Figure 2). The large catalog of the presently 
identified mouse distal “enhancers” may allow to look for muta-
tions and polymorphisms in the corresponding human enhanc-
ers (if conserved) to facilitate the search for genetic variation 
responsible for brain inherited disease and for predisposition to 
schizophrenia and autism spectrum disorders.
Perspectives for More In-depth Studies of the 
Functional Interactome
While HiC and ChIA-PET provide an extensive catalog of 
(potentially) all the interactions, they have some limitations. 
These techniques detect multiple gene promoters brought 
together through chromatin interactions from the collection of 
Figure 3. Two models for aggregated chromatin interactions.
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large number of cells. Two different models can account for 
these aggregated chromatin interactions: specific, pairwise pro-
moter-enhancer interactions, or multivalent, in parallel chroma-
tin interactions between different promoters and multiple 
regulatory modules. That is, the enhancer activity could be tar-
get-specific, combinatorial, or both (Figure 3). Moreover, some 
of the region-specific interactions are identified by large num-
bers of sequencing reads, whereas other interactions are rare; the 
latter ones are likely present only in a small proportion of the 
cells in the population. An assessment of functional roles of the 
interaction would ideally require the knowledge of which inter-
actions are present simultaneously on each gene region in a 
given cell. Such an analysis has been made recently possible (in 
Drosophila cells) by a new technique (ChIA-Drop).15 In ChIA-
Drop, individual chromatin complexes are partitioned into 
droplets with single gel bead containing unique DNA-barcoded 
primers, such that all the chromatin fragments within each 
droplet have the same barcodes and can be distinguished fol-
lowing linear amplification. The amplified barcoded DNAs are 
then pooled for high-throughput sequencing. Sequencing reads 
having identical barcodes are grouped as multivalent and repre-
sent combinatorial chromatin interactions between each 
enhancers with all corresponding genes targets (Figure 3) which 
identifies fragments present within single “drops” containing 
individual chromatin fragments from single cells.15 If this tech-
nique can be applied to mouse or human cells, it will allow addi-
tional understanding of the function of the interactome. This 
will be particularly interesting when analyzing the simultaneous 
interactions of the enhancer component, revealing whether 
interaction of a given enhancer is, at any specific time, limited to 
a single gene, or extended to multiple different genes.
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